Finland· FI-REL-REL57348
Akynzeo
A palonosetron, kombinationen product containing fosnetupitant chloride hydrochloride + palonosetron hydrochloride, registered in Finland by Helsinn Birex Pharmaceuticals Ltd. The same ATC class is registered in 11 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Palonosetron, kombinationen is registered in 11 of 19 countries.
Countries holding a registration under ATC A04AA55 (palonosetron, kombinationen), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 7 of them publish a price we can compare per daily dose
Palonosetron, kombinationen · ATC A04AA55
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of palonosetron, kombinationen costs, country by country.
Normalised to the WHO defined daily dose (0.5 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Palonosetron, kombinationen · price per daily dose (0.5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.20
The record
At a glance
Fimea (Finland)- Active substance
- Fosnetupitant chloride hydrochloride + Palonosetron hydrochloride
- Manufacturer
- Helsinn Birex Pharmaceuticals Ltd
- Country
- Finland (FI)
- ATC code
- A04AA55
- ATC class
- Palonosetron, Kombinationen
- Defined daily dose
- 0.5 mg, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Palonosetron, kombinationen in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/475821fb-8a47-4d32-b997-79a8a475836e GET /v1/drugs/475821fb-8a47-4d32-b997-79a8a475836e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "infuusiokonsentraatti, liuosta varten",
"route": "Laskimoon",
"ddd_unit": null,
"strength": "235 mg / 0.25 mg",
"atc_label": "palonosetroni, yhdistelmävalmisteet",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/1/15/1001/004",
"fimea_rel_id": "REL57348",
"authorised_at": "2021-11-12"
}See everything about palonosetron, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.